GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vireo Growth Inc (XCNQ:VREO) » Definitions » Cyclically Adjusted Price-to-FCF

Vireo Growth (XCNQ:VREO) Cyclically Adjusted Price-to-FCF : (As of Jun. 05, 2025)


View and export this data going back to 2005. Start your Free Trial

What is Vireo Growth Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Vireo Growth Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Vireo Growth's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vireo Growth Cyclically Adjusted Price-to-FCF Chart

Vireo Growth Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vireo Growth Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vireo Growth's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Vireo Growth's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vireo Growth's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vireo Growth's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Vireo Growth's Cyclically Adjusted Price-to-FCF falls into.


;
;

Vireo Growth Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Vireo Growth's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Vireo Growth's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.017/134.9266*134.9266
=-0.017

Current CPI (Mar. 2025) = 134.9266.

Vireo Growth Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.027 100.684 -0.036
201509 -0.009 100.392 -0.012
201512 -0.009 99.792 -0.012
201603 -0.003 100.470 -0.004
201606 0.003 101.688 0.004
201609 -0.003 101.861 -0.004
201612 -0.441 101.863 -0.584
201703 -0.048 102.862 -0.063
201706 -0.015 103.349 -0.020
201709 -0.006 104.136 -0.008
201712 -0.273 104.011 -0.354
201803 -0.006 105.290 -0.008
201806 -0.037 106.317 -0.047
201809 -0.101 106.507 -0.128
201812 -0.017 105.998 -0.022
201903 -0.066 107.251 -0.083
201906 -0.475 108.070 -0.593
201909 -0.616 108.329 -0.767
201912 -0.202 108.420 -0.251
202003 -0.051 108.902 -0.063
202006 -0.077 108.767 -0.096
202009 -0.067 109.815 -0.082
202012 -0.059 109.897 -0.072
202103 -0.107 111.754 -0.129
202106 -0.181 114.631 -0.213
202109 -0.089 115.734 -0.104
202112 -0.113 117.630 -0.130
202203 -0.088 121.301 -0.098
202206 -0.048 125.017 -0.052
202209 -0.033 125.227 -0.036
202212 -0.071 125.222 -0.077
202303 -0.043 127.348 -0.046
202306 -0.007 128.729 -0.007
202309 0.004 129.860 0.004
202312 -0.026 129.419 -0.027
202403 -0.020 131.776 -0.020
202406 -0.031 132.554 -0.032
202409 -0.050 133.029 -0.051
202412 -0.056 133.157 -0.057
202503 -0.017 134.927 -0.017

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vireo Growth  (XCNQ:VREO) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Vireo Growth Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Vireo Growth's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Vireo Growth Business Description

Industry
Traded in Other Exchanges
Address
207 South 9th Street, Minneapolis, Minneapolis, MN, USA, 55402
Vireo Growth Inc is a cannabis company whose mission is to provide safe access, quality products, and value to its customers while supporting its local communities through active participation and restorative justice programs. The company's operating results in one business segment: the cultivation, production, and sale of cannabis.
Executives
Llc Chicago Atlantic Credit Opportunities 10% Security Holder

Vireo Growth Headlines

No Headlines